StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Panacea Life Sciences's ebitda for the twelve months ending Dec 31, 2016 was -$1.60M. For fiscal 2018 it was -$2.03M. The highest annual figure on record is -$387.66K in fiscal 2015.

Annual ebitda

PeriodPeriod endValueChange
FY2018Dec 31, 2018-$2.03M–
FY2017Dec 31, 2017-$3.07M–
FY2016Dec 31, 2016-$1.60M–
FY2015Dec 31, 2015-$387.66K–
FY2014Dec 31, 2014-$418.47K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2021Sep 30, 2021-$474.86K–
Q3 FY2020Sep 30, 2020-$2.45M–
Q4 FY2016Dec 31, 2016-$747.43K–
Q3 FY2016Sep 30, 2016-$359.81K–
Q2 FY2016Jun 30, 2016-$260.87K–
Q1 FY2016Mar 31, 2016-$233.37K–
Q4 FY2015Dec 31, 2015-$69.40K–
Q1 FY2015Mar 31, 2015-$63.42K–
Q4 FY2014Dec 31, 2014-$239.97K–
Q3 FY2014Sep 30, 2014-$74.45K–
Q2 FY2014Jun 30, 2014-$16.67K–

More Panacea Life Sciences figures

See a number that looks wrong?